# Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy

> **NCT02836652** · PHASE4 · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 72 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** HeartMate II (HMII)
- **DRUG:** Warfarin
- **DRUG:** acetylsalicylic acid (ASA) therapy

## Key facts

- **NCT ID:** NCT02836652
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11
- **Primary completion:** 2019-02-21
- **Final completion:** 2019-07-18
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2022-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02836652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02836652, "Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02836652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*